A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children

American Journal of Tropical Medicine and Hygiene

Volumn 58, Issue 5, 1998, Pages 638-644

  Von Seidlein, Lorenz ^a   Bojang, Kalifa ^b   Jones, Peter ^b   Jaffar, Shabbar ^b   Pinder, Margaret ^b   Obaro, Steven ^b   Doherty, Tom ^b   Haywood, Michelle ^c   Snounou, Georges ^d   Gemperli, Beatrice ^e   Gathmann, Insa ^e   Royce, Catherine ^e   McAdam, Keith ^b   Greenwood, Brian ^c  

^a Haiti c/o Agape Flights Inc   (United States)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d NORTHWICK PARK HOSPITAL   (United Kingdom)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISININ; ATOVAQUONE; BENFLUMETOL; CHLOROQUINE; FANSIDAR; HALOFANTRINE; MEFLOQUINE; PROGUANIL; UNCLASSIFIED DRUG;

ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FEVER; GAMETOCYTE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MULTICENTER STUDY; PARASITEMIA; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

PROTOZOA;

EID: 17344382730     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.58.638     Document Type: Article

References (20)

1. Butler D, Maurice J, O'Brien C, 1997. Time to put malaria on the global agenda. Nature 386: 535-536.
2. World Bank, 1993. World Development Report 1993; Investing in Health. New York: Oxford University Press.
3. Ronn AM, Msangeni HA, Mhina J, Wernsdorfer WH, Bygbjerg IC, 1996. High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Trans R Soc Trop Med Hyg 90: 179-181.
4. Onyiorah E, Boele van Hensbroek M, Jah MS, Greenwood BM, 1996. Early clinical failures after pyrimethamine-sulfadoxine treatment of uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg 90: 307-308.
5. Radloff PD, Philipps J, Nkeyi M, Hutchinson D, Kremsner PG, 1996. Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet 347: 1511-1514.
6. Ringwald P, Bickii J, Basco L, 1996. Randomized trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet 347: 24-28.
7. Meshnick SR, Taylor TE, Kamchonwongpaisan S, 1996. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol Rev 60: 301-315.
8. von Seidlein L, Jaffar S, Pinder M, Haywood M, Snounou G, Gemperli B, Gathmann I, Royce C, Greenwood BM, 1997. Treatment of African children with uncomplicated falciparum malaria with a new antimalarial CGP 56697. J Infect Dis 176: 1113-1116.
9. Viriyakosol S, Siripoon N, Petcharapirat C, Petcharapirat P, Jarra W, Thaithong S, Brown KN, Snounou G, 1995. Genotyping of Plasmodium falciparum isolates by the polymerase chain reaction and potential uses in epidemiologic studies. Bull World Health Organ 73: 85-95.
10. George S, 1984. The required sample size and length of a phase III clinical trial. Buyse ME, Staquet MJ, Sylvester RJ, eds. Cancer Clinical Trials: Methods and Practice. Oxford: Oxford University Press, 287-310.
11. Karbwang J, Bangchang KN, Thanavibul A, Bunnag D, Chongsuphajaisiddhi T, Harinasuta T, 1992. Comparison of oral artemether and mefloquine in acute uncomplicated falciparum malaria. Lancet 340: 1245-1248.
12. Looareesuwan S, Viravan C, Vanijanonta S, Wilairatana P, Suntharasamai P, Charoenlarp P, Arnold K, Kyle D, Canfield C, Webster K, 1992. Randomized trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Lancet 339: 821-824.
13. Goodman Gilman A, Rail T, Nies A., Taylor P, 1990. Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: Pergamon Press.
14. Edstein M, 1984. Quantification of antimalarial drugs. II. Simultaneous measurement of dapsone, monoacetyldapsone and pyrimethamine in human plasma. J Chromatogr 307: 426-431.
15. Edstein M, 1984. Quantification of antimalarial drugs. I. Simultaneous measurement of sulphadoxine. N4-acetylsulphadoxine and pyrimethamine in human plasma. J Chromatogr 306: 502-507.
16. Heligren U, Kihamia CM, Bergqvtst Y, Lebbad M, Premji Z, Rombo L, 1990. Standard and reduced doses of sulfadoxinepyrimethamine for treatment of Plasmodium falciparum in Tanzania, with determination of drug concentrations and susceptibility in vitro. Trans R Soc Trop Med Hyg 84: 469-472.
17. Na-Bangchang K, Karbwang J, Thomas CG, Thanavibul A, Sukontason K, Ward SA, Edwards G, 1994. Pharmacokinetics of artemether after oral administration to healthy Thai males and patients with acute uncomplicated falciparum malaria. Br J Clin Pharmacol 37: 249-253.
18. Navaratnam V, Mansor SM, Chin LK, Mordi MN, Asokan N, Nair NK, 1995. Determination of artemether and dihydroartemisinin in blood plasma by high performance liquid chromatography for application in clinical pharmacological studies. J Chromatogr 669: 289-294.
19. Lindsay S, Campbell H, Adiamah J, Greenwood A, Bangali J, Greenwood B, 1990. Malaria in a periurban area of The Gambia. Ann Trop Med Parasitol 84: 553-562.
20. Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ, 1996. Effects of artemisinin derivatives on malaria transmissibility. Lancet 347: 1654-1658.